SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-16-014543
Filing Date
2016-11-10
Accepted
2016-11-10 16:16:16
Documents
58
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2016 l103116010q.htm 10-Q 741293
2 EXHIBIT 10.2 ex10_2.htm EX-10.2 104122
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 7475
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 7482
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 5006
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 5071
  Complete submission text file 0001214659-16-014543.txt   4182010

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kbio-20160930.xml EX-101.INS 807238
8 XBRL TAXONOMY EXTENSION SCHEMA kbio-20160930.xsd EX-101.SCH 38813
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kbio-20160930_cal.xml EX-101.CAL 52197
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kbio-20160930_def.xml EX-101.DEF 163548
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kbio-20160930_lab.xml EX-101.LAB 381687
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kbio-20160930_pre.xml EX-101.PRE 251746
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 161988239
SIC: 2834 Pharmaceutical Preparations